¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12
±³À°ÀÏÀÚ : 2020-11-12
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È­»ó °­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѾฮÇÐȸ
´ã´çÀÚ : À庴ȣ 
¿¬¶ôó : 02-326-0370  
À̸ÞÀÏ : head@kosphar.org      
±³À°Á¾·ù : ¾à¸®ÇР     
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 220,000¿ø      
ºñ°í ÆòÀÇ¿ø, Á¤È¸¿ø: 150,000¿ø ÁØȸ¿ø: 80,000¿ø,ºñȸ¿ø: 220,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 12ÀÏ  09:30~09:50 Molecular and Cellular Mechanisms in the Pathogenesis of Chronic Traumatic Encephalopathy (CTE)  ·ùÈÆ(KIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:50~10:10 Lipocalin-2 in the secondary brain injury  ¼®°æÈ£(°æºÏ´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:10~10:30 Cerebrovascular recovery after stroke via Plexin-D1 signaling activation  ¿À¿øÁ¾(Çѱ¹³ú¿¬±¸¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:30~10:50 Caveolin-1 target microRNA-X attenuates blood-brain injury after cerebral ischemia  ±èÇü¼®(Àü³²´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:30~09:50 CTCF-mediated Genomic Effects of BART Region on Epstein-Barr virus 3D Chromatin Structure  °­È¿Á¤(°æºÏ´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:50~10:10 Application of nanobiotechnology for diagnosis and prevention against spillover viral infections Disease X  ¼Û´ë¼·(°í·Á´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:10~10:30 Identification of Antiviral Drug Candidates against SARS-CoV-2 FDA-Approved Drugs  ±è½ÂÅÃ(Çѱ¹ ÆĽºÅ𸣿¬±¸¼Ò) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:30~10:50 Development of Antiviral Agents: Influenza, Zika and Coronavirus  ±èÁ¤±â(°í·Á´ë ¾à´ë) 
Åä·Ð 11¿ù 12ÀÏ  10:50~11:10 ÁúÀÇ ¹× ÀÀ´ä  () 
È޽Ġ11¿ù 12ÀÏ  11:10~11:30 Coffee Break  () 
±³À°½Ã°£ 11¿ù 12ÀÏ  11:30~12:20 Smart Mouse Model for Precision Medicine  ¼ºÁ¦°æ(¼­¿ï´ë) 
½Ä»ç 11¿ù 12ÀÏ  12:20~13:20 Á߽Ġ () 
±âŸ 11¿ù 12ÀÏ  13:20~14:20 Æ÷½ºÅÍ ¼¼¼Ç  () 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:20~14:40 Molecular deconvolution identifies &quotmesenchymal-ness  Á¤ÀçÈ£(¿¬¼¼´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:40~15:00 Immunotherapy for complicated pregnancy associated and cellular immune abnormality  À̼º±â(°Ç¾ç´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:00~15:20 Leukocyte Specific Protein (LSP)-1 Regulation of Lymphocyte Functions  ±è¿Ï¿í(°¡Å縯´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:20~15:40 Translational approaches discovery to clinical proof of concept  ÀÓµ¿¼®(°¡Å縯´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:20~14:40 Data Driven Drug Discovery Research Platform at Korea Chemical Bank  À̼±°æ(È­Çבּ¸¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:40~15:00 Induced Pluripotent Stem Cell in Disease Modelling and Drug Screening Platform  ÀÌÀçö(¼º±Õ°ü´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:00~15:20 Silicon neural probe for modulation and measurement of neural activities in vivo and in vitro  Á¶ÀÏÁÖ(KIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:20~15:40 Long-term 3D culture of primary hepatocyte in nanofibrous membrane  °ûÁ¾¿µ(¾ÆÁÖ´ë ÀÇ´ë) 
Åä·Ð 11¿ù 12ÀÏ  15:40~17:00 ÁúÀÇ ¹× ÀÀ´ä  () 
±âŸ 11¿ù 12ÀÏ  16:00~16:30 ½Ã»ó½Ä - Æóȸ½Ä  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÇ·á À±¸®ÀÇ ÀÌÇØ : 2020-11-12
´ÙÀ½±Û ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ÃæºÏÁöȸ ¿¬¼ö°­Á : 2020-11-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
557 ºÎ»ê ´ëÇѺ´¸®ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ À¯¹æ ¹× ºñ´¢»ý½Ä±â°è º´¸®ÀÇ ÃÖ½ÅÁö°ß : 2018-09-04 0 906 2018-08-29
556 ¼­¿ï ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ ¿ù·ÊÁý´ãȸ : 2018-09-04 0 958 2018-08-29
555 ¼­¿ï Á¦37ȸ ´ëÇѹ̿ë¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-02 0 1,956 2018-08-29
554 ¼­¿ï Á¦ 4ȸ ´ëÇѰ˾ÈÇÐȸ ±¼Àý°Ë»ç¿Í ¾È°æó¹æ Workshop : 2018-09-30 0 1,024 2018-08-22
553 ºÎ»ê 2018³â ºÎ»ê¿ï»ê°æ³² ½Å°æ°úÁöȸ Ãß°èÇмú´ëȸ : 2018-09-29 0 1,144 2018-08-22
552 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö±³À°(ÁßÀÌ¿°) : 2018-09-28 0 1,303 2018-08-22
551 ¼­¿ï ¿øÀڷº´¿ø Á¦38ȸ°³¿øÀÇ ¿¬¼ö°­ÁÂ(È£Èí±âÁúȯ) : 2018-09-20 0 2,290 2018-08-22
550 ´ë±¸ ÆÄƼ¸¶º´¿ø ´ë±¸°æºÏÇ÷¾×ÁöºÎÇÐȸ : 2018-09-19 0 913 2018-08-22
549 Ãæ³² ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 1. ÀÓ»óÁ¤½ÅÀÇÇÐ , 2. ¹Ýº¹Àû ÀÚÇØ ½Ãµµ û¼Ò³â¿¡ ´ëÇÑ ÀÌÇØ : 2018-09-18 0 5,053 2018-08-22
548 ÀüºÏ Á¦3Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ È£³²Áöȸ Çмú´ëȸ : 2018-09-18 0 699 2018-08-22
547 ÃæºÏ ±¹¸³ÀÇ·á¿ø °ø°øÀÇ·á Consensus Conference(CEO±³À°) : 2018-09-17 0 1,387 2018-08-22
546 ºÎ»ê µ¿¾Æ´ëÇб³º´¿ø ´ëÇѼÒÈ­±âÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2018-09-17 0 1,610 2018-08-22
545 ºÎ»ê ºÎ»ê´ëÇб³º´¿ø °³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ Áõ·Ê ´Ù½Ã º¸±â¿Í ´ÙÃÊÁ¡ Àΰø¼öÁ¤Ã¼ Ư°­ : 2018-09-16 0 1,949 2018-08-22
544 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø ECHO SEOUL 2018 : 2018-09-16 0 1,417 2018-08-22
543 ¼­¿ï 2018 ´ëÇÑÀ忬±¸ÇÐȸ ¿¬¼ö°­Á : 2018-09-16 0 795 2018-08-22
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷